Tissue penetration of antimicrobials: Difference between revisions
From IDWiki
(ββ) |
m (ββ) |
||
Line 13: | Line 13: | ||
| rowspan="3" |[[Penicillins]] |
| rowspan="3" |[[Penicillins]] |
||
|Ξ²-lactamase inhibitors |
|Ξ²-lactamase inhibitors |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[ampicillin]] |
|[[ampicillin]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
|- |
|- |
||
|[[piperacillin-tazobactam]] |
|[[piperacillin-tazobactam]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | +β |
|||
| +β |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
| rowspan="5" |[[Cephalosporins]] |
| rowspan="5" |[[Cephalosporins]] |
||
|first-generation cephalosporins |
|first-generation cephalosporins |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
|- |
|- |
||
|second-generation cephalosporins |
|second-generation cephalosporins |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|third-generation cephalosporins |
|third-generation cephalosporins |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | +β |
|||
| +β |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[cefepime]] |
|[[cefepime]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
|[[ceftazidime]] |
|[[ceftazidime]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
| rowspan="2" |[[Cephamycins]] |
| rowspan="2" |[[Cephamycins]] |
||
|[[cephamycins]] |
|[[cephamycins]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[cefoxitin]] |
|[[cefoxitin]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
|- |
|- |
||
|[[Carbapenems]] |
|[[Carbapenems]] |
||
|[[imipenem]] |
|[[imipenem]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
Line 95: | Line 95: | ||
|- |
|- |
||
|[[Aminoglycosides]] |
|[[Aminoglycosides]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
|- |
|- |
||
|[[Chloramphenicol]] |
|[[Chloramphenicol]] |
||
|[[chloramphenicol]] |
|[[chloramphenicol]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
|[[Fluoroquinolones]] |
|[[Fluoroquinolones]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β? |
| style="text-align:center" |β? |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
Line 120: | Line 120: | ||
|[[Fosfomycin]] |
|[[Fosfomycin]] |
||
|[[fosfomycin]] |
|[[fosfomycin]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
|||
| + |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[Lincosamides]] |
|[[Lincosamides]] |
||
|[[clindamycin]] |
|[[clindamycin]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
|[[Macrolides]] |
|[[Macrolides]] |
||
|[[macrolides]] |
|[[macrolides]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[Nitrofurans]] |
|[[Nitrofurans]] |
||
Line 152: | Line 152: | ||
|[[Nitroimidazoles]] |
|[[Nitroimidazoles]] |
||
|[[metronidazole]] |
|[[metronidazole]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
|[[Rifamycins]] |
|[[Rifamycins]] |
||
|[[rifampin]] |
|[[rifampin]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[Sulfonamides]] |
|[[Sulfonamides]] |
||
|[[trimethoprim-sulfamethoxazole]] |
|[[trimethoprim-sulfamethoxazole]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
| rowspan="2" |[[Tetracyclines]] |
| rowspan="2" |[[Tetracyclines]] |
||
|[[tetracyclines]] |
|[[tetracyclines]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
| style="text-align:center" |β |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
|[[doxycycline]] |
|[[doxycycline]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
|||
| + |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
Line 193: | Line 193: | ||
|[[Azoles]] |
|[[Azoles]] |
||
|[[fluconazole]] |
|[[fluconazole]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
| style="text-align:center" | + |
||
|- |
|- |
||
|[[Echinocandins]] |
|[[Echinocandins]] |
||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | + |
|||
| + |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" |β |
|||
|β |
|||
| style="text-align:center" | |
|||
| |
|||
| style="text-align:center" | |
|||
| |
|||
|- |
|- |
||
!Class |
!Class |
Revision as of 18:50, 16 September 2020
Summary
Class | Antimicrobial | Blood | CNS | Urine | Prostate | Necrotic |
---|---|---|---|---|---|---|
Antibiotics: Ξ²-Lactams | ||||||
Penicillins | Ξ²-lactamase inhibitors | β | ||||
ampicillin | + | β | ||||
piperacillin-tazobactam | +β | |||||
Cephalosporins | first-generation cephalosporins | β | β | |||
second-generation cephalosporins | β | |||||
third-generation cephalosporins | +β | |||||
cefepime | + | |||||
ceftazidime | + | + | ||||
Cephamycins | cephamycins | β | ||||
cefoxitin | β | |||||
Carbapenems | imipenem | + | ||||
Antibiotics: Non-Ξ²-Lactams | ||||||
Aminoglycosides | β | |||||
Chloramphenicol | chloramphenicol | + | ||||
Fluoroquinolones | β? | + | + | |||
Fosfomycin | fosfomycin | + | ||||
Lincosamides | clindamycin | β | + | |||
Macrolides | macrolides | β | + | |||
Nitrofurans | nitrofurantoin | β | β | + | β | β |
Nitroimidazoles | metronidazole | + | ||||
Rifamycins | rifampin | + | ||||
Sulfonamides | trimethoprim-sulfamethoxazole | + | ||||
Tetracyclines | tetracyclines | β | + | |||
doxycycline | + | + | ||||
Antifungals | ||||||
Azoles | fluconazole | + | ||||
Echinocandins | + | β | ||||
Class | Antimicrobial | Blood | CNS | Urine | Prostate | Necrotic |
- β if inflammation present
Prostate
- Poorly penetrated by most antibiotics
- Penetration is higher with a high concentration gradient, high lipid solubility, low degree of ionization, high dissociation constant, low protein binding, and small molecular size
- Fluoroquinolones are the mainstay of therapy, though there is increasing resistance
- TMP-SMX often used, though conflicting data about its penetration into the prostate
- Minocycline, doxycycline, and macrolides achieve high levels in the prostate but are rarely indicated for the causative organisms
- Third-generation cephalosporins and carbapenems can be used
- Piperacillin, aztreonam, imipenem, and some aminoglycosides are likely useful
References
- ^ Cornelia B. Landersdorfer, JΓΌrgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz SΓΆrgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
- ^ L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.